These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29189366)

  • 21. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
    Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL; Givone DM
    Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.
    McMillin GA; Slawson MH; Marin SJ; Johnson-Davis KL
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):322-39. PubMed ID: 24147959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy.
    Doyle K; Strathmann FG
    Pain Med; 2017 Feb; 18(2):307-315. PubMed ID: 28204701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of urine drug monitoring in chronic opioid therapy: an analysis of current clinician behavior.
    Clancy Z; O'Connell K; Couto J
    J Opioid Manag; 2013; 9(2):121-7. PubMed ID: 23709321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Urine Drug Screen Sensitivity in Adolescent Opioid Presentations to the Emergency Department.
    Sidlak A; Dhaliwal M
    Pediatr Emerg Care; 2024 Sep; 40(9):650-653. PubMed ID: 38950407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?
    Mullins ME; Hock K; Scott MG
    Clin Toxicol (Phila); 2015 Jun; 53(5):493-4. PubMed ID: 25951899
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: The role of urine drug testing for patients on opioid therapy.
    Collen MR
    Pain Pract; 2011; 11(2):199; author reply 199. PubMed ID: 21371255
    [No Abstract]   [Full Text] [Related]  

  • 31. The implications of urine drug testing in pain management.
    Vadivelu N; Chen IL; Kodumudi V; Ortigosa E; Gudin MT
    Curr Drug Saf; 2010 Jul; 5(3):267-70. PubMed ID: 20394568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls.
    Von Seggern RL; Fitzgerald CP; Adelman LC; Adelman JU
    Headache; 2004 Jan; 44(1):44-7. PubMed ID: 14979882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of buprenorphine LUCIO immunoassay versus GC-MS using urines from a workplace drug testing program.
    Alves MN; Piccinotti A; Tameni S; Polettini A
    J Anal Toxicol; 2013 Apr; 37(3):175-8. PubMed ID: 23408251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferences with urine drug screens.
    Herring C; Muzyk AJ; Johnston C
    J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine drug testing: current recommendations and best practices.
    Owen GT; Burton AW; Schade CM; Passik S
    Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory and clinical evaluation of on-site urine drug testing.
    Beck O; Carlsson S; Tusic M; Olsson R; Franzen L; Hulten P
    Scand J Clin Lab Invest; 2014 Nov; 74(8):681-6. PubMed ID: 25046332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine drug testing for pain management.
    Magnani B; Kwong T
    Clin Lab Med; 2012 Sep; 32(3):379-90. PubMed ID: 22939297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine Drug Screens in the Emergency Department: The Best Test May Be No Test at All.
    Stellpflug SJ; Cole JB; Greller HA
    J Emerg Nurs; 2020 Nov; 46(6):923-931. PubMed ID: 32843202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users.
    Palamar JJ; Le A; Guarino H; Mateu-Gelabert P
    Drug Alcohol Depend; 2019 Jul; 200():161-167. PubMed ID: 31146203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.